Latest News - Cardinal Health
Top Corporates Hub
Cardinal Health
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
29.08.2025 13:40
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should You Add Zimmer Biomet Stock to Your Portfolio Now?
28.08.2025 12:11
ZBH rides on knee innovation and robotics growth, but debt and macro pressures challenge its upside potential.
Cooper Companies Likely to Beat Q3 Earnings Estimate on Lens Demand
26.08.2025 12:22
COO's Q3 results may top estimates, powered by strong demand for MyDay lenses, Biofinity gains and surgical product resilience despite fertility softness.
Cardinal Health (NYSE:CAH) Will Pay A Dividend Of $0.5107
21.08.2025 10:16
Cardinal Health, Inc. ( NYSE:CAH ) has announced that it will pay a dividend of $0.5107 per share on the 15th of...
5 Must-Read Analyst Questions From Cardinal Health’s Q2 Earnings Call
19.08.2025 05:30
Cardinal Health’s second quarter results were met with a significant negative market reaction, largely due to flat sales and a notable miss on adjusted EBITDA versus Wall Street expectations. Management cited robust demand in pharmaceutical distribution and growth in specialty services, but also acknowledged that individually small, unexpected expenses and ongoing cost pressures weighed on the bottom line. CEO Jason Hollar highlighted operational efficiencies and the impact of recent acquisition
The Pricey Stock Market Will Continue Climbing, Says Analyst. 2 Sectors to Watch, and 1 to Avoid.
11.08.2025 18:16
Despite trading at record highs, the S&P 500 can continue to climb on earnings and productivity, argues Adam Parker of Trivariate Research.
Cardinal Health Q4 Preview: Accelerating Autoimmune, Urology, And Oncology, Buy
11.08.2025 13:39
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology. Learn more on CAH stock here.
TNDM Stock Falls on Q2 Earnings Miss, Revenues Beat, Gross Margin Up
11.08.2025 11:53
Tandem Diabetes posts record Q2 sales and higher margins, but earnings miss sends shares tumbling 20%.
Cardinal Health (CAH) Q2 Earnings Report Preview: What To Look For
11.08.2025 03:01
Healthcare distributor and services company Cardinal Health (NYSE:CAH) will be announcing earnings results this Tuesday before market open. Here’s what to look for.
CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View
06.08.2025 13:24
Charles River shares jump 9.3% pre-market after Q2 earnings and revenues beat estimates. The company raises its 2025 outlook.
Cencora raises annual profit forecast on strong demand for specialty drugs
06.08.2025 11:50
U.S. drug distributor Cencora raised its annual profit forecast on Wednesday after posting quarterly earnings that topped Wall Street estimates, buoyed by surging demand for specialty therapies and blockbuster weight-loss drugs. The Philadelphia-based company now expects its annual adjusted profit between $15.85 and $16.00 per share, up from its previous expectation of $15.70 to $15.95 per share. Analysts, had expected a profit of $15.83 per share, according to LSEG data.
Sila Realty Trust Completes Acquisition of a Two-Property Medical Outpatient Building Portfolio for $16.15 Million
04.08.2025 10:30
TAMPA, Fla., August 04, 2025--Sila Realty Trust Completes Acquisition of a Two-Property Medical Outpatient Building Portfolio for $16.15 Million
Cardinal Health Insiders Sell US$18m Of Stock, Possibly Signalling Caution
02.08.2025 13:00
Many Cardinal Health, Inc. ( NYSE:CAH ) insiders ditched their stock over the past year, which may be of interest to...
Charles River Q2 Earnings Preview: What's in Store for the Stock?
30.07.2025 12:20
CRL gears up for Q2 earnings with expected revenue and EPS declines amid mixed segment performance.
Cardinal Health Foundation expands Equity Rx to increase access to prescription medications, bringing total investment to $5M
30.07.2025 10:20
Cardinal Health (NYSE:CAH) announced today the expansion of Equity Rx, to help meet the needs of people across Ohio and beyond who cannot afford their prescription medications. Launched as a pilot in Ohio in 2023, Equity Rx was created through a partnership of the Cardinal Health Foundation, the Charitable Healthcare Network (CHN) (an Ohio charitable healthcare organization) and St. Vincent de Paul Charitable Pharmacy in Cincinnati, Ohio. With this most recent grant, the Foundation has invested
ISRG Stock Gains on Q2 Earnings & Sales Beat, Gross Margin Contracts
23.07.2025 12:35
Intuitive Surgical's second-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
Cardinal Health Earnings Preview: What to Expect
23.07.2025 10:29
Cardinal Health is preparing to announce its second-quarter results next month, and analysts are anticipating an earnings surge in the double digits.
[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
23.07.2025 08:30
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Inferior Vena Cava IVC Filter Market size & share revenue was valued at approximately USD 895.82 Million in 2024 and is expected to reach USD 974.16 Million in 2025 and is expected to reach around USD 2,094.10 Million by 2034, at a CAGR of 8.88% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Abbott, B.
Labcorp Q2 Earnings Preview: Diagnostics Strength in Focus
21.07.2025 12:30
LH is likely to report Q2 growth with diagnostics momentum, key acquisitions, and new biomarker tests bolstering revenue gains.
DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance?
21.07.2025 12:05
Quest Diagnostics' Q2 results may get a lift from Advanced Diagnostics, new health plan deals and recent acquisitions.